NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 251 filers reported holding NOVAVAX INC in Q3 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,078 | -85.2% | 10,508 | -79.0% | 0.00% | -100.0% |
| Q4 2022 | $514,062 | -49.2% | 50,006 | -10.0% | 0.00% | -50.0% |
| Q3 2022 | $1,012,000 | -56.3% | 55,588 | +23.4% | 0.00% | -60.0% |
| Q2 2022 | $2,317,000 | +5.9% | 45,046 | +51.6% | 0.01% | +25.0% |
| Q1 2022 | $2,188,000 | -41.6% | 29,711 | +13.5% | 0.00% | -42.9% |
| Q4 2021 | $3,745,000 | +0.2% | 26,175 | +45.2% | 0.01% | -12.5% |
| Q3 2021 | $3,736,000 | -0.3% | 18,023 | +2.1% | 0.01% | 0.0% |
| Q2 2021 | $3,747,000 | -0.9% | 17,650 | -15.3% | 0.01% | -11.1% |
| Q1 2021 | $3,780,000 | +52.6% | 20,846 | -6.2% | 0.01% | +50.0% |
| Q4 2020 | $2,477,000 | +10.7% | 22,216 | +7.6% | 0.01% | 0.0% |
| Q3 2020 | $2,237,000 | +16.4% | 20,643 | -10.5% | 0.01% | 0.0% |
| Q2 2020 | $1,921,000 | +961.3% | 23,052 | +72.8% | 0.01% | +500.0% |
| Q1 2020 | $181,000 | – | 13,338 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 90,000 | $4,629,000 | 1.95% |
| Affinity Asset Advisors, LLC | 85,000 | $4,372,000 | 1.84% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 6,814 | $132,500,000 | 1.38% |
| Mendel Capital Management LLC | 23,835 | $1,226,000 | 1.37% |
| Faithward Advisors, LLC | 80,143 | $4,122,000 | 0.92% |
| Coatue Management | 1,241,716 | $63,861,000 | 0.77% |
| Rock Springs Capital Management LP | 475,100 | $24,434,000 | 0.71% |
| SECTOR GAMMA AS | 55,324 | $2,845,000 | 0.64% |
| SevenOneSeven Capital Management | 5,103 | $262,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 49,200 | $2,530,000 | 0.51% |